[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Endo
Itsuro
I
Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences.
Matsumoto
Toshio
T
D000818:Animals; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016723:Bone Remodeling; D002986:Clinical Trials as Topic; D015195:Drug Design; D005260:Female; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control; D005269:Femur / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D008159:Lumbar Vertebrae / Q000378:metabolism; D008297:Male; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control; D019379:Teriparatide / Q000008:administration & dosage* / Q000009:adverse effects
D050071:Bone Density Conservation Agents; D019379:Teriparatide